Vivimed Labs Limited — Others, 07-05-2025: Disclosure under SEBI Takeover Regulations

The company has announced a board meeting to review the financial results for the quarter and half-year. This evaluation will offer insights into recent operational performance and financial health, influencing investor sentiment and future business planning. No updates on strategy or dividends were provided, keeping the focus on assessing financial outcomes and ensuring transparent management oversight for shareholders.